Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (36)
Gabriele De Rubis, Keshav Raj Paudel, Venkata Sita Rama Raju Allam, Vamshikrishna Malyla, Vetriselvan Subramaniyan, Sachin Kumar Singh, Nisha Panth, Gaurav Gupta, Philip Michael Hansbro, Dinesh Kumar Chellappan & Kamal Dua. (2024) Involvement of osteopontin, EpCAM, estrogen receptor-alpha, and carbonic anhydrase IX protein in managing lung cancer via Berberine-loaded liquid crystalline nanoparticles. Pathology - Research and Practice 253, pages 154971.
Crossref
Crossref
Valéria Tavares, Beatriz Vieira Neto, Inês Soares Marques, Joana Assis, Deolinda Pereira & Rui Medeiros. (2024) Cancer-associated thrombosis: What about microRNAs targeting the tissue factor coagulation pathway?. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1879:1, pages 189053.
Crossref
Crossref
Arefeh Zabeti Touchaei, Sogand Vahidi & Ali Akbar Samadani. (2023) Decoding the interaction between miR-19a and CBX7 focusing on the implications for tumor suppression in cancer therapy. Medical Oncology 41:1.
Crossref
Crossref
Vamshikrishna Malyla, Gabriele De Rubis, Keshav Raj Paudel, Dinesh Kumar Chellappan, Nicole G. Hansbro, Philip M. Hansbro & Kamal Dua. (2023) Berberine nanostructures attenuate ß-catenin, a key component of epithelial mesenchymal transition in lung adenocarcinoma. Naunyn-Schmiedeberg's Archives of Pharmacology 396:12, pages 3595-3603.
Crossref
Crossref
Qi Wang, Hua Wu, Qingquan Wu & Sheng Zhong. (2023) Berberine targets KIF20A and CCNE2 to inhibit the progression of nonsmall cell lung cancer via the PI3K/AKT pathway. Drug Development Research 84:5, pages 907-921.
Crossref
Crossref
Yao Sun, Cheng-ling Yu, Yun-liang Yan, Feng-ling Zhang, Jing Chen, Zi-yi Hu, Jia He, Xiong-yu Meng & Qiao-feng Wu. (2023) Inhibitory Effects and Related Molecular Mechanisms of Huanglian-Ganjiang Combination Against H1N1 Influenza Virus. Revista Brasileira de Farmacognosia 33:3, pages 514-522.
Crossref
Crossref
Xinyi Wang, Gonghuan Tang, Hui Guo, Jingjing Ma, Dongmei Liu, Yuwei Wang, Ruyi Jin, Zhi Li & Yuping Tang. (2023) Research Progress on the Anti-Tumor Mechanism and Reversal of Multidrug Resistance of Zuojin Pill and its Main Components, Evodiamine and Berberine. Natural Product Communications 18:3, pages 1934578X2311614.
Crossref
Crossref
Huaizhu Guo, Siqi Lu, Jindong Zhang, Chen Chen, Yanlin Du, Kun Wang & Liping Duan. (2023) Berberine and rifaximin effects on small intestinal bacterial overgrowth: Study protocol for an investigator-initiated, double-arm, open-label, randomized clinical trial (BRIEF-SIBO study). Frontiers in Pharmacology 14.
Crossref
Crossref
Liang Xu. (2023) Identification of Autophagy-Related Targets of Berberine against Non-Small Cell Lung Cancer and Their Correlation with Immune Cell Infiltration By Combining Network Pharmacology, Molecular Docking, and Experimental Verification. Critical Reviews in Immunology 43:2, pages 27-47.
Crossref
Crossref
Ijeoma Theresa Achi, Paromita Sarbadhikary, Blassan P. George & Heidi Abrahamse. (2022) Multi-Target Potential of Berberine as an Antineoplastic and Antimetastatic Agent: A Special Focus on Lung Cancer Treatment. Cells 11:21, pages 3433.
Crossref
Crossref
Saleh A. Almatroodi, Mohammed A. Alsahli & Arshad Husain Rahmani. (2022) Berberine: An Important Emphasis on Its Anticancer Effects through Modulation of Various Cell Signaling Pathways. Molecules 27:18, pages 5889.
Crossref
Crossref
Wenwen Gu, Mengdi Zhang, Fan Gao, Yuji Niu, Luyao Sun, Haojie Xia, Wenwen Li, Yaru Zhang, Zhenzhen Guo & Gangjun Du. (2022) Berberine regulates PADI4-related macrophage function to prevent lung cancer. International Immunopharmacology 110, pages 108965.
Crossref
Crossref
Sayedeh Azimeh Hosseini, Morvarid Seidi & Hajar Yaghoobi. (2022) Designed miR-19a/b sponge induces apoptosis in lung cancer cells through the PI3K-PTEN-Akt pathway regulation. Molecular Biology Reports 49:9, pages 8485-8493.
Crossref
Crossref
Qingxi Yue, Wen Zhang, Shumeng Lin, Tiansheng Zheng, Yaqin Hou, Yanfei Zhang, Ziye Li, Kai Wang, Liduo Yue, Baigenzhin Abay, Ming Li & Lihong Fan. (2022) Ejiao ameliorates lipopolysaccharide-induced pulmonary inflammation via inhibition of NFκB regulating NLRP3 inflammasome and mitochondrial ROS. Biomedicine & Pharmacotherapy 152, pages 113275.
Crossref
Crossref
Ruo-Gu Xiong, Si-Yu Huang, Si-Xia Wu, Dan-Dan Zhou, Zhi-Jun Yang, Adila Saimaiti, Cai-Ning Zhao, Ao Shang, Yun-Jian Zhang, Ren-You Gan & Hua-Bin Li. (2022) Anticancer Effects and Mechanisms of Berberine from Medicinal Herbs: An Update Review. Molecules 27:14, pages 4523.
Crossref
Crossref
Keshav R. Paudel, Meenu Mehta, Geena Hew Suet Yin, Lee Li Yen, Vamshikrishna Malyla, Vyoma K. Patel, Jithendra Panneerselvam, Thiagarajan Madheswaran, Ronan MacLoughlin, Niraj Kumar Jha, Piyush Kumar Gupta, Sachin Kumar Singh, Gaurav Gupta, Pradeep Kumar, Brian G. Oliver, Philip M. Hansbro, Dinesh Kumar Chellappan & Kamal Dua. (2022) Berberine-loaded liquid crystalline nanoparticles inhibit non-small cell lung cancer proliferation and migration in vitro. Environmental Science and Pollution Research 29:31, pages 46830-46847.
Crossref
Crossref
Abdullah Alnuqaydan, Abdulmajeed Almutary, Mohd Azam, Bikash Manandhar, Geena Yin, Lee Yen, Thiagarajan Madheswaran, Keshav Paudel, Philip Hansbro, Dinesh Chellappan & Kamal Dua. (2022) Evaluation of the Cytotoxic Activity and Anti-Migratory Effect of Berberine–Phytantriol Liquid Crystalline Nanoparticle Formulation on Non-Small-Cell Lung Cancer In Vitro. Pharmaceutics 14:6, pages 1119.
Crossref
Crossref
Anna Och, Marek Och, Renata Nowak, Dominika Podgórska & Rafał Podgórski. (2022) Berberine, a Herbal Metabolite in the Metabolic Syndrome: The Risk Factors, Course, and Consequences of the Disease. Molecules 27:4, pages 1351.
Crossref
Crossref
Suliman Khan, Arif Hussain, Farnoosh Attar, Samir Haj Bloukh, Zehra Edis, Majid Sharifi, Ebrahim Balali, Fahimeh Nemati, Hossein Derakhshankhah, Hojjat Alizadeh Zeinabad, Faisal Nabi, Rizwan Hasan Khan, Xiao Hao, Yueting Lin, Linlin Hua, Timo L.M. ten Hagen & Mojtaba Falahati. (2022) A review of the berberine natural polysaccharide nanostructures as potential anticancer and antibacterial agents. Biomedicine & Pharmacotherapy 146, pages 112531.
Crossref
Crossref
Lulu Ni, Ping Sun, Xiaochun Fan, Zhongjie Li, Hongli Ren & Jiangan Li. (2022) Berberine Inhibits FOXM1 Dependent Transcriptional Regulation of POLE2 and Interferes With the Survival of Lung Adenocarcinoma. Frontiers in Pharmacology 12.
Crossref
Crossref
Yi Zhu, Na Xie, Yilu Chai, Yisen Nie, Ke Liu, Yufei Liu, Yang Yang, Jinsong Su & Chuantao Zhang. (2022) Apoptosis Induction, a Sharp Edge of Berberine to Exert Anti-Cancer Effects, Focus on Breast, Lung, and Liver Cancer. Frontiers in Pharmacology 13.
Crossref
Crossref
Shumeng Lin, Jing Wen, Xiao Xu, Jiamin Shi, Wen Zhang, Tiansheng Zheng, Yaqin Hou, Yanfei Zhang, Ziye Li, Kai Wang, Jing Jin, Liduo Yue, Baigenzhin Abay, Ming Li, Qingxi Yue & Lihong Fan. (2022)
Amygdalin Induced Mitochondria-Mediated Apoptosis of Lung Cancer Cells via Regulating NFκB-1/NFκB Signaling Cascade
in Vitro
and
in Vivo
. The American Journal of Chinese Medicine 50:05, pages 1361-1386.
Crossref
Crossref
Meenu Mehta, Vamshikrishna Malyla, Keshav R. Paudel, Dinesh Kumar Chellappan, Philip M. Hansbro, Brian G. Oliver & Kamal Dua. (2021) Berberine loaded liquid crystalline nanostructure inhibits cancer progression in adenocarcinomic human alveolar basal epithelial cells in vitro. Journal of Food Biochemistry 45:11.
Crossref
Crossref
Xiao-Hong Guo, Shui-Shan Jiang, Li-Li Zhang, Jun Hu, Dilda Edelbek, Yu-Qi Feng, Zi-Xian Yang, Peng-Chao Hu, Hua Zhong, Guo-Hua Yang & Fang Yang. (2021) Berberine exerts its antineoplastic effects by reversing the Warburg effect via downregulation of the Akt/mTOR/GLUT1 signaling pathway. Oncology Reports 46:6.
Crossref
Crossref
Parisa Maleki Dana, Moghadeseh Jahanshahi, Bita Badehnoosh, Rana Shafabakhsh, Zatollah Asemi & Jamal Hallajzadeh. (2021) Inhibitory effects of berberine on ovarian cancer: Beyond apoptosis. Medicinal Chemistry Research 30:9, pages 1605-1613.
Crossref
Crossref
Hua Xu, Xiao Wang, Yinghong Zhang, Wei Zheng & Huijie Zhang. (2021) GATA6‑AS1 inhibits ovarian cancer cell proliferation and migratory and invasive abilities by sponging miR‑19a‑5p and upregulating TET2. Oncology Letters 22:4.
Crossref
Crossref
Win Sen Heng, Frank A. E. Kruyt & Shiau-Chuen Cheah. (2021) Understanding Lung Carcinogenesis from a Morphostatic Perspective: Prevention and Therapeutic Potential of Phytochemicals for Targeting Cancer Stem Cells. International Journal of Molecular Sciences 22:11, pages 5697.
Crossref
Crossref
The Hong Phong Nguyen, V. Bharath Kumar, Vinoth Kumar Ponnusamy, Thi Thu Thao Mai, Phuong Tran Nhat, Kathirvel Brindhadevi & Arivalagan Pugazhendhi. (2021) Phytochemicals intended for anticancer effects at preclinical levels to clinical practice: Assessment of formulations at nanoscale for non-small cell lung cancer (NSCLC) therapy. Process Biochemistry 104, pages 55-75.
Crossref
Crossref
Ganesh C. Jagetia. (2021) Anticancer Potential of Natural Isoquinoline Alkaloid Berberine. Journal of Exploratory Research in Pharmacology 000:000, pages 000-000.
Crossref
Crossref
Tingting Wen, Lei Song & Shucheng Hua. (2021) Perspectives and controversies regarding the use of natural products for the treatment of lung cancer. Cancer Medicine 10:7, pages 2396-2422.
Crossref
Crossref
Tian-Jia Liu, Shuang Hu, Zhi-Dong Qiu & Da Liu. (2021) Anti-Tumor Mechanisms Associated With Regulation of Non-Coding RNA by Active Ingredients of Chinese Medicine: A Review. Frontiers in Oncology 10.
Crossref
Crossref
Anna Och, Rafał Podgórski & Renata Nowak. (2020) Biological Activity of Berberine—A Summary Update. Toxins 12:11, pages 713.
Crossref
Crossref
Yaru Zhang, Xiaojiang Liu, Min Yu, Minmin Xu, Yaping Xiao, Wenyu Ma, Lu Huang, Xuegang Li & Xiaoli Ye. (2020) Berberine inhibits proliferation and induces G0/G1 phase arrest in colorectal cancer cells by downregulating IGF2BP3. Life Sciences 260, pages 118413.
Crossref
Crossref
Maura Calvani, Angela Subbiani, Gennaro Bruno & Claudio Favre. (2020) Beta-Blockers and Berberine: A Possible Dual Approach to Contrast Neuroblastoma Growth and Progression. Oxidative Medicine and Cellular Longevity 2020, pages 1-11.
Crossref
Crossref
Ce Tang, Cheng-Cheng Zhao, Huan Yi, Zang-Jia Geng, Xin-Yue Wu, Yi Zhang, Ya Liu & Gang Fan. (2020) Traditional Tibetan Medicine in Cancer Therapy by Targeting Apoptosis Pathways. Frontiers in Pharmacology 11.
Crossref
Crossref
Solomon Habtemariam. (2020) Berberine pharmacology and the gut microbiota: A hidden therapeutic link. Pharmacological Research 155, pages 104722.
Crossref
Crossref